Maria Dolores Cayero-Otero

Maria Dolores Cayero-Otero

Auto-generated profile, based on publicly available information

Maria Dolores Cayero-Otero

Departamento de Farmacia y Tecnologia Farmaceutica, Universidad de Sevilla, Sevilla, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Pharmacological Research
Verified
Journal Article
Closed access
JLJulia Jiménez López
Julia Jiménez López
MEMazen M. El-Hammadi
Mazen M. El-Hammadi
RORaul Ortiz
Raul Ortiz
MCMaria D. Cayero-Otero
Maria D. Cayero-Otero
LCLaura Cabeza
Laura Cabeza
CMConsolación Melguizo
Consolación Melguizo

2 December 2019 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
COCayero- Otero
Cayero- Otero
MGMaria João Gomes
Maria João Gomes
CMCláudia Martins
Cláudia Martins
JÁJ. Álvarez-Fuentes
J. Álvarez-Fuentes
MFM. Fernández-Arévalo
M. Fernández-Arévalo
LMLucía Martín
Lucía Martín
Background: Actually, no drugs provide therapeutic benefit to approximately one third of depressed patients. Depression is predicted to become the first global disease by 2030. So, new therapeutic interventions are imperative. Research design and methods: Venlafaxine loaded-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) were surface functionalized with two ligands against transferrin receptor to enhance access to brain. An in vitro blood-brain barrier model using hCMEC/D3 cell line was developed to evaluate permeability. In vivo biodistribution studies were performed using C57/bl6 mice. Particles were administered intranasal and main organs were analyzed. Results: Particles were obtained as a lyophilized powder easily to re-suspend. Internalization and permeability studies showed the following cell association sequence: TfRp-NPs>Tf-NPs>plain NPs. Permeability studies also showed that encapsulated VLF was not affected by P-gP pump efflux increasing its concentration in the basolateral side after 24h. In vivo studies showed that 25% of plain NPs reach the brain after 30 min of one intranasal administration while less than 5% of functionalized NPs get the target. Conclusions:Plain NPs showed the highest ability to reach the brain vs functionalized NPs after 30 min by intranasal administration. We suggest plain NPs probably travel via direct nose-to-brian route whereas functionalized NPs reach the brain by receptor-mediated endocytosis.

13 February 2019 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
A. Alper ÖztürkA. Alper Öztürk
A. Alper Öztürk
LBLucia Martin Banderas
Lucia Martin Banderas
MOMaria D. Cayero Otero
Maria D. Cayero Otero
EYEvrim Yenilmez
Evrim Yenilmez
BŞBehiye Şenel
Behiye Şenel
YYYasemin Yazan
Yasemin Yazan
Dexketoprofen trometamol-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles: Preparation, in vitro characterization and cyctotoxity

13 July 2018 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
MCMaria Dolores Cayero-Otero
Maria Dolores Cayero-Otero
AEAna M. Espinosa-Oliva
Ana M. Espinosa-Oliva
AHAntonio J. Herrera
Antonio J. Herrera
Irene García DomínguezIrene García Domínguez
Irene García Domínguez
MFMercedes Fernandez-Arevalo
Mercedes Fernandez-Arevalo
RPRocio M. de Pablos
Rocio M. de Pablos
Neurodegenerative diseases, like Alzheimer´s and Parkinson´s disease, are a group of disorders that have in common their increasingly high prevalence along with the shortage of effective treatments. In addition, the scientific community faces the challenge of getting the drugs used in these treatments to cross the blood-brain barrier (BBB) and reach the brain in sufficient concentration to be able to exert its effect. Hence, researchers across multiple disciplines are working together in order to improve the ability of therapeutics to penetrate the BBB. In this sense, the use of nanomedicine, nanoscale structures for drug delivery, exhibits a really high therapeutic potential in the field of neurodegenerative diseases therapy. Since there is new evidence that neuroinflammation produced by reactive microglia contributes to the activation and pathogenesis of neurological disorders, many investigations focus on the identification of new targets whose inhibition can reduce, totally or partially, microglial activation. This review analyzes a wide variety of compounds as possible candidates to achieve this target, from compounds with a natural origin to anti-diabetics, antidepressants, antibiotics and hormones. We also discuss the different strategies to enhance the capacity of these compounds to cross the BBB. Although this review focuses on PLGA nanoparticles as one of the most versatile drug delivery nanosystems, we also describe other strategies, such as direct intranasal administration (nose-tobrain), novel viral vectors and novel implanted catheters.

1 January 2024
Verified
Book Chapter
Closed access
MOMª Dolores Cayero Otero
Mª Dolores Cayero Otero
Este trabajo incluye el desarrollo y los resultados que se han obtenido tras la aplicación de un Ciclo de Mejora en el Aula (CIMA) en la asignatura obligatoria Legislación, Gestión y Planificación Farmacéutica del 4º curso del Grado en Farmacia (curso 2023-2024). La temática principal de las prácticas es que los alumnos conozcan la legislación vigente y el funcionamiento básico de una oficina de farmacia (OF) ya que, en meses venideros, se enfrentarán a sus prácticas tuteladas. Por lo tanto, el principal objetivo del presente CIMA es la integración de los alumnos en situaciones reales de casos extraídos de diferentes OF de la provincia de Sevilla a través de un role-play donde actuarán como pacientes o farmacéuticos. Los alumnos han mostrado gran interés en este tipo de aprendizaje, obteniéndose resultados que ponen de manifiesto la utilidad práctica del CIMA para que los alumnos aprendan y sean capaces de desarrollar lo aprendido. Así mismo, ellos se sienten más motivados e integrados con la asignatura, sintiéndose como auténticos profesionales.